Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
38.2%
% of WDNA's 91 holdings also in BTEC
15.9%
% of BTEC's 220 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus BTEC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in BTEC |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 1.9% | 2.3% | 1.9% |
|
BRIDGEBIO PHARMA, INC. | 2.0% | 1.4% | 1.4% |
|
BLUEPRINT MEDICINES CORP. | 2.2% | 1.4% | 1.4% |
|
IONIS PHARMACEUTICALS, INC. | 1.2% | 1.5% | 1.2% |
|
SAREPTA THERAPEUTICS INC | 1.1% | 2.6% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to BTEC
|
IOVANCE BIOTHERAPEUTICS INC | 2.9% |
|
FATE THERAPEUTICS INC | 2.8% |
|
TWIST BIOSCIENCE CORP. | 2.7% |
 |
NOVOZYMES A/S-B SHARES | 2.4% |
|
ELI LILLY & CO | 1.9% |
|
CRISPR THERAPEUTICS AG | 1.8% |
|
CARIBOU BIOSCIENCES, INC. | 1.4% |
|
EDITAS MEDICINE, INC. | 1.4% |
 |
ALCOBRA LTD | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 1.3% |
WDNA Underweight Relative to BTEC
|
KARUNA THERAPEUTICS, INC. | -2.7% |
|
ELANCO ANIMAL HEALTH, INC. | -1.8% |
|
CYTOKINETICS INC | -1.7% |
|
APELLIS PHARMACEUTICALS, INC. | -1.7% |
|
INTRA-CELLULAR THERAPIES INC | -1.6% |
|
VAXCYTE, INC. | -1.6% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | -1.5% |
|
ALNYLAM PHARMACEUTICALS INC | -1.5% |
|
SAREPTA THERAPEUTICS INC | -1.4% |
|
EXACT SCIENCES CORP | -1.4% |